CD69 and COVID-19: Of interest, an altered expression of various receptors involved in migration, adhesion and activation, including CXCR4, CD63 and CD69, have been reported in COVID-19, highlighting specific immunophenotypes with predictive potential for clinical outcomes [52,53].